Our position on counterfeit medicines
What is a counterfeit medicine?
A counterfeit medicine is one which is deliberately and fraudulently mislabelled with respect to identity or source. Counterfeiting occurs with both branded and generic products and counterfeit products may include products with the correct ingredients or with the wrong ingredients, without active ingredients, with insufficient quantities of active ingredients or with fake packaging. (Source: World Health Organisation)
How Novo Nordisk combats counterfeit products
Counterfeit healthcare products is an important issue for the pharmaceutical industry and represent a public health risk because the contents of counterfeit products are not known.
We work against counterfeiting by:
- having a quality management system that investigates occurrences of counterfeited Novo Nordisk products
- cooperating internationally with scientific and trade organisations as well as regulatory bodies to develop legislation to counteract counterfeit products
- cooperating with regulators and other stakeholders to investigate counterfeit products and to develop new anti-counterfeit measures
- communicating timely and openly about cases of counterfeit products found in the Novo Nordisk supply chain to minimise the safety risk that use of such products may pose.
- considering legal action against those involved in the counterfeiting of Novo Nordisk products
- being a member of the Pharmaceutical Security Institute (PSI) which collects information and coordinates investigations into counterfeit products within the pharmaceutical industry worldwide.